First Time Loading...

Diffusion Pharmaceuticals Inc
NASDAQ:DFFN

Watchlist Manager
Diffusion Pharmaceuticals Inc Logo
Diffusion Pharmaceuticals Inc
NASDAQ:DFFN
Watchlist
Price: 9.25 USD 6.69%
Updated: May 8, 2024

Diffusion Pharmaceuticals Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Diffusion Pharmaceuticals Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Diffusion Pharmaceuticals Inc
NASDAQ:DFFN
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$29.5B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
19%

See Also

What is Diffusion Pharmaceuticals Inc's Revenue?
Revenue
0 USD

Based on the financial report for Jun 30, 2023, Diffusion Pharmaceuticals Inc's Revenue amounts to 0 USD.